Quotient Wealth Partners’s Boston Scientific BSX Stock Holding History

Quotient Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Sell	4,929 -966	-16%	-$77.3K	0.01%	277
2025 Q4	$562K	Sell	5,895 -356	-6%	-$34.9K	0.02%	175
2025 Q3	$610K	Buy	6,251 +287	+5%	+$29.7K	0.02%	166
2025 Q2	$641K	Buy	5,964 +543	+10%	+$54.9K	0.02%	157
2025 Q1	$547K	Buy	5,421 +376	+7%	+$37.9K	0.02%	166
2024 Q4	$451K	Buy	5,045 +285	+6%	+$25.1K	0.01%	189
2024 Q3	$399K	Buy	4,760 +71	+2%	+$5.6K	0.01%	204
2024 Q2	$361K	Buy	4,689 +553	+13%	+$40.5K	0.01%	218
2024 Q1	$283K	Buy	4,136 +578	+16%	+$37.2K	0.01%	238
2023 Q4	$206K	Buy	+3,558	New	+$190K	0.01%	270

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quotient Wealth Partners's BSX Position: Q1 2026 in Review

Quotient Wealth Partners reduced its Boston Scientific (BSX) stake by 16% in Q1 2026, selling an estimated $77.3K and leaving 4,929 shares worth $309K. The position accounts for 0.01% of the portfolio, ranked #277.

Quotient Wealth Partners first reported a position in BSX in Q4 2023 and has held it in 10 quarters since. The position peaked at $641K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Quotient Wealth Partners held 4,929 shares of Boston Scientific worth $309K as of Q1 2026.
Quotient Wealth Partners sold 966 Boston Scientific shares in Q1 2026, an estimated $77.3K.
Boston Scientific made up 0.01% of Quotient Wealth Partners's portfolio in Q1 2026, its #277 holding.
Quotient Wealth Partners first reported a position in Boston Scientific in Q4 2023 and has held it in 10 quarters since.
Quotient Wealth Partners's Boston Scientific position peaked at $641K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.